Exploring how genetic diversity affects Alzheimer's Disease risk in Latino populations
Understanding the role of genetic admixture on Alzheimer’s Disease risk in Latíno Populations
This study is looking at how different genetic backgrounds might affect the chances of getting Alzheimer's Disease in Latino communities, with the hope of finding new ways to prevent or treat the disease based on individual genetics.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Colorado Denver NIH-funded |
| Lab location | 1 site (Aurora, UNITED STATES) |
| Project ID | NIH-10887585 on NIH RePORTER |
What this research studies
This research investigates the impact of genetic admixture on the risk of developing Alzheimer's Disease (AD) specifically in Latino populations. By analyzing genetic variations and their relationship to AD, the study aims to identify potential risk factors that may contribute to the disease. The approach includes examining the role of specific proteins, such as Kinesin-5, that are influenced by amyloid beta, a key player in AD pathology. Patients may benefit from insights that could lead to targeted prevention strategies or treatments based on their genetic background.
Who could benefit from this research
Good fit: Ideal candidates for this research are Latino individuals who may be at risk for Alzheimer's Disease due to genetic factors.
Not a fit: Patients who do not identify as Latino or those who do not have a family history of Alzheimer's Disease may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to personalized prevention strategies for Alzheimer's Disease in Latino populations.
How similar studies have performed: Previous research has shown promising results in understanding genetic factors related to Alzheimer's Disease, suggesting that this approach could yield valuable insights.
Where this research is happening
Aurora, UNITED STATES
- University of Colorado Denver — Aurora, United States (Active)
Researchers
- Principal investigator: Lucero, Esteban M — University of Colorado Denver
- Study coordinator: Lucero, Esteban M
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.